Pharmaceutical Packaging Equipment Market Report 2025

The pharmaceutical packaging equipment market size has grown rapidly in recent years. It will grow from $12.03 billion in 2024 to $13.27 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to automation advancements, serialization and track & trace implementation, integration of smart packaging technologies, green and sustainable packaging.

The pharmaceutical packaging equipment market size is expected to see rapid growth in the next few years. It will grow to $21.49 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to operational efficiency focus, pharmaceutical supply chain complexity, sustainable packaging solutions, rapid growth in pharmaceutical industry, regulatory compliance requirements. Major trends in the forecast period include automation and robotics, advanced serialization and track & trace, personalized medicine packaging, flexible and modular packaging solutions, green and sustainable packaging.

The anticipated rise in the aging population is poised to elevate the prevalence of age-related ailments, thereby contributing to the expansion of both the pharmaceutical drugs and pharmaceutical packaging equipment markets. The global elderly demographic is experiencing rapid growth, a trend expected to persist throughout the forecast period. According to a report from the Centers for Disease Control and Prevention (CDC), the population aged 65 years and above in the USA is projected to reach approximately 71 million by 2030 and 98 million by 2060. Moreover, it is estimated that by 2030, China will account for nearly half of the global Parkinson's disease population, a phenomenon attributed to the country's aging demographic. This anticipated surge in the aging population grappling with age-related ailments is forecasted to be a key driver behind the growth of the pharmaceutical packaging equipment market.

The growing demand for personalized medicine is anticipated to drive the expansion of the pharmaceutical packaging equipment market in the future. Personalized medicine, characterized by tailoring healthcare decisions and medical treatments to the unique characteristics of each patient, necessitates specialized packaging solutions. Pharmaceutical packaging equipment plays a crucial role in personalized medicine by facilitating precise and individualized dosing, secure containment, and accurate labeling to meet the distinctive packaging requirements of personalized drug formulations. As an illustration, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), as reported by the Personalized Medicine Coalition, a US-based professional membership organization. Out of these approvals, approximately 34%, equivalent to 12 therapeutic NMEs, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for personalized medicine serves as a catalyst for the growth of the pharmaceutical packaging equipment market.

The pharmaceutical packaging equipment market is witnessing a growing adoption of automatic packaging machines, which efficiently handle the supply of packing materials and contents, automating various stages of the packaging process. A case in point is the global launch of the automated in-line packing machine Cut'it! EVO by Ranpak, a US-based paper packaging company, in September 2022. Engineered to elevate packaging output, lower operational costs, and bolster sustainability in customer operations, this machine provides tangible benefits such as enhanced sustainability and reduced shipping volume. The increased utilization of such automatic packaging machines underscores a strategic industry shift towards optimizing efficiency and sustainability in pharmaceutical packaging processes.

Leading companies in the pharmaceutical packaging equipment market are emphasizing innovative product development, such as Clinical Trial Kits, to improve the efficiency and accuracy of drug distribution and administration in clinical trials. A Clinical Trial Kit includes a pre-packaged set of medical supplies, drugs, and equipment for use in clinical trials, ensuring consistent and standardized distribution. This advancement enhances efficiency, regulatory compliance, and the precise, timely distribution of trial materials within the pharmaceutical packaging equipment market. For example, in February 2023, Gerresheimer AG, a Germany-based provider of pharmaceutical and cosmetic packaging solutions and drug delivery systems, launched its Clinical Trial Kit - a sterile Gx RTF vial specifically designed for early clinical development of new drugs, vaccines, and biologics. This kit, tailored for small batch manufacturing, offers six configurations, including Gx Elite and Gx RTF COP options, and simplifies the clinical development process, adhering to GMP requirements. Gerresheimer also offers regulatory guidance and laboratory services, reinforcing its role as a partner in pharmaceutical development.

In June 2024, ALPLA Group, an Austria-based manufacturer of rigid plastic packaging solutions, including blow-molded bottles, caps, injection-molded parts, preforms, and tubes, acquired Heinlein Plastik-Technik for an undisclosed amount. This strategic acquisition aims to expand its offerings in primary packaging solutions, enhance injection molding capacities, and establish a technology center at Heinlein's Ansbach location. Heinlein Plastik-Technik GmbH, a Germany-based company, specializes in the development and manufacture of closure systems, dosing systems, and application aids specifically for the pharmaceutical and medical sectors.

Major companies operating in the pharmaceutical packaging equipment market include Robert Bosch GmbH, Thermo Fisher Scientific Inc., GEA Group AG, Korber AG, Coesia S.P.A., Industria Macchine Automatiche S.p.A., Associated Capsules Group of Companies, CCL Container Corp, Optima Packaging Group GmbH, Marchesini Group S.p.A., Uhlmann Pac-Systeme GmbH & Co, Tekni-Plex, Inc., Harro Hofliger Verpackungsmaschinen GmbH, Romaco Holding GmbH, Bausch + Strobel Maschinenfabrik Ilshofen GmbH + Co KG, IWK Verpackungstechnik GmbH, Phoenix Packaging Inc., N.k.p. Pharma Private Limited, ARPAC LLC, Aero Precision Corp, MG2 s.r.l., Vanguard Pharmaceutical Machinery LLC, Accutek Packaging Equipment Companies, Dara Pharmaceutical Packaging, Rommelag AG, Trustar Pharma & Packing Equipment Co Ltd., Multivac Sepp Haggenmuller GmbH & Co KG, Groninger & Co GmbH, Valois Industries Inc., Blister Packaging Holdings Ltd.

North America was the largest region in the pharmaceutical packaging equipment market in 2024. Asia-Pacific was the second-largest market in the pharmaceutical packaging equipment market. The regions covered in the pharmaceutical packaging equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical packaging equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pharmaceutical packaging equipment comprises various components such as equipment, piping, instruments, electrical items, and related accessories. These elements are fabricated and assembled in a workshop, typically mounted on a skid for convenient connection. The equipment is designed for the packaging of pharmaceutical products, utilizing flexible and heat-sealable materials to create packages that are filled with a product and subsequently sealed.

The main types of products in pharmaceutical packaging equipment are primary packaging equipment, secondary packaging equipment, and labeling and sterilization equipment. Primary packaging equipment is in direct contact with the product, acting as a consumer unit that encases and contains the drug product. Secondary packaging equipment is responsible for providing high-quality corrugated cardboard packaging with finished prints. Secondary packaging refers to the exterior packaging that groups and further protects or labels the drug product. Labeling and sterilization equipment is used to add usage directions and sterilize the packaging environment. Various types of pharmaceutical packaging equipment include blenders, granulators, tablet pressers, tablet coating machines, and allied machines, contributing to the efficient and secure packaging of pharmaceutical products.

The pharmaceutical packaging equipment market research report is one of a series of new reports that provides pharmaceutical packaging equipment market statistics, including pharmaceutical packaging equipment industry global market size, regional shares, competitors with a pharmaceutical packaging equipment market share, detailed pharmaceutical packaging equipment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical packaging equipment industry. This pharmaceutical packaging equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceuticals packaging equipment market consists of sales of accumulating and collating machines, blister packs, skin packs and vacuum packaging machines, bottle caps equipment, over-capping, lidding, closing, seaming and sealing machines, box, case, tray, and carrier forming, packing, unpacking, closing, and sealing machines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.